These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26228667)

  • 1. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
    Wyler von Ballmoos MC; Haring B; Sacks FM
    J Clin Lipidol; 2015; 9(4):498-510. PubMed ID: 26228667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
    Chan DC; Nguyen MN; Watts GF; Barrett PH
    J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
    Breyer ED; Le NA; Li X; Martinson D; Brown WV
    J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.
    Ooi EM; Chan DT; Watts GF; Chan DC; Ng TW; Dogra GK; Irish AB; Barrett PH
    J Lipid Res; 2011 Apr; 52(4):794-800. PubMed ID: 21297177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease.
    Mendivil CO; Rimm EB; Furtado J; Chiuve SE; Sacks FM
    Circulation; 2011 Nov; 124(19):2065-72. PubMed ID: 21986282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.
    Kohan AB
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):119-25. PubMed ID: 25692924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.
    Gugliucci A; Lustig RH; Caccavello R; Erkin-Cakmak A; Noworolski SM; Tai VW; Wen MJ; Mulligan K; Schwarz JM
    Atherosclerosis; 2016 Oct; 253():171-177. PubMed ID: 27451002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
    Dunbar RL; Nicholls SJ; Maki KC; Roth EM; Orloff DG; Curcio D; Johnson J; Kling D; Davidson MH
    Lipids Health Dis; 2015 Sep; 14():98. PubMed ID: 26328624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation analysis of lipids and apolipoproteins in plasma HDL, LDL and VLDL of normal subjects and endogenous hypertriglyceridemics].
    Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):141-5. PubMed ID: 7490018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
    Chan DC; Chen MM; Ooi EM; Watts GF
    Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects.
    Rodríguez M; Rehues P; Iranzo V; Mora J; Balsells C; Guardiola M; Ribalta J
    J Proteomics; 2022 Jan; 251():104398. PubMed ID: 34688878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.
    Mendivil CO; Rimm EB; Furtado J; Sacks FM
    J Am Heart Assoc; 2013 May; 2(3):e000130. PubMed ID: 23672999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
    Yamamoto R; Sacks FM; Hu FB; Rosner B; Furtado JD; Aroner SA; Ferrannini E; Baldi S; Kozakova M; Balkau B; Natali A; Jensen MK;
    Atherosclerosis; 2018 Feb; 269():92-99. PubMed ID: 29351856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
    Aroner SA; Furtado JD; Sacks FM; Tsai MY; Mukamal KJ; McClelland RL; Jensen MK
    Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Composition and distribution of lipid and apolipoprotein in plasma lipoproteins of endogenous hypertriglyceridemia].
    Zhang L; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):117-21. PubMed ID: 1452137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.
    Bukberg PR; Le NA; Ginsberg HN; Gibson JC; Rubinstein A; Brown WV
    J Lipid Res; 1985 Sep; 26(9):1047-57. PubMed ID: 4067427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
    Cohn JS; Patterson BW; Uffelman KD; Davignon J; Steiner G
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.